Department of Urology

October 12, 2023

Prostate cancer survivors symposium set for Nov. 11

Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.

By Tom Wilemon
August 10, 2023

New leaders named to Vanderbilt-Ingram research programs

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.

By Tom Wilemon
A Vanderbilt Institute for Surgery and Engineering team working to create a navigational system to decrease stone fragments left behind after surgery includes Nicholas Kavoussi, MD, left, Ipek Oguz, PhD, and Daiwei Lu. (photo by Susan Urmy)
August 8, 2023

VISE team works to develop 3D navigation system to better treat kidney stones

A multidisciplinary team at Vanderbilt is working to create a real-time navigational system to decrease residual stone fragments left behind after kidney stone surgery. 

By Jill Clendening
April 20, 2023

Overactive bladder and anxiety

Anxiety and psychological stress impact hypersensitivity mechanisms in women that could contribute to overactive bladder — a frequent and sudden urge to urinate that is difficult to control.

By Sarah E. Glass
April 3, 2023

More U.S. prostate cancer patients choosing active surveillance

A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

By Craig Boerner
Roger Dmochowski, MD, with Female Pelvic Medicine and Reconstructive Surgery Urology fellows Stephanie Gleicher, MD, MPH, left, who graduates in June, and Rosa Park, MD.
March 30, 2023

Urology fellowship program celebrated after 20 years

The urology fellowship training program focused on women’s urologic health and reconstruction, known as Female Pelvic Medicine and Reconstructive Surgery, is celebrating its 20th anniversary and graduating its 20th fellow in June at Vanderbilt University Medical Center.

By Craig Boerner
March 23, 2023

New MyHealth Bundles to help treat kidney stones, substance use disorder

Employees covered by Vanderbilt University Medical Center health plans and employees covered by the Metro Nashville Public Schools health plan can now enroll in two new MyHealth Bundles: MyUrologyHealth for the treatment of kidney stones and MyRecoveryHealth for the treatment of substance use disorder.
By Jill Clendening
March 23, 2023

E. coli uses serine to abide acidity

Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies.
By Cherie Saffold
February 9, 2023

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.
By Craig Boerner
October 27, 2022

Study reveals pathways for aggressive prostate cancer subtype

Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.
By Tom Wilemon
September 26, 2022

Gender differences with bladder pain

Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.
By Leigh MacMillan
August 25, 2022

Study describes how E. coli co-opts cells, causes recurrent UTIs

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.
By Bill Snyder
August 17, 2022

Donation leads to lectureship for Urologic Oncology

A generous donation is leading to the Hassell Franklin Lectureship for the Division of Urologic Oncology at Vanderbilt University Medical Center.
By Craig Boerner